Curaleaf Expects Major Growth of Legal Marijuana in U.S.

The video discusses the growth of the cannabis market in the US and Europe, highlighting the rapid expansion in the US due to state-level legalization. Curaleaf's focus on the US market is emphasized, but the company is also investing in Europe, where the market is seen as having significant potential. The regulatory environment in Europe is more favorable for medical cannabis, allowing for a capital-light model. Challenges in the US include varied state regulations, leading to high capital expenditures. A strategic investment in Europe is seen as a sign of the market's potential.

How does the capital light model in Europe benefit cannabis operations?

What challenges do US-based cannabis businesses face due to varying state regulations?

What potential growth opportunities exist in the European cannabis market according to the text?